Reliq Health Technologies Stock Net Income
| RQHTF Stock | USD 0.01 0.00 0.00% |
As of the 3rd of March, Reliq Health holds the Risk Adjusted Performance of 0.1041, coefficient of variation of 812.4, and Variance of 1485000.0. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Reliq Health, as well as the relationship between them. Please check Reliq Health Technologies risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if Reliq Health Technologies is priced some-what accurately, providing market reflects its current price of 0.01 per share. As Reliq Health Technologies appears to be a penny stock we also advise to check out its information ratio numbers.
Reliq Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Reliq Health's valuation are provided below:Reliq Health Technologies does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Reliq |
Reliq Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Reliq Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Reliq Health.
| 12/03/2025 |
| 03/03/2026 |
If you would invest 0.00 in Reliq Health on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Reliq Health Technologies or generate 0.0% return on investment in Reliq Health over 90 days. Reliq Health is related to or competes with Talis Biomedical. Reliq Health Technologies Inc., a telemedicine company, develops virtual care solutions for the healthcare market More
Reliq Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Reliq Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Reliq Health Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.123 | |||
| Maximum Drawdown | 9900.0 |
Reliq Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Reliq Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Reliq Health's standard deviation. In reality, there are many statistical measures that can use Reliq Health historical prices to predict the future Reliq Health's volatility.| Risk Adjusted Performance | 0.1041 | |||
| Jensen Alpha | 155.11 | |||
| Total Risk Alpha | 36.86 | |||
| Treynor Ratio | (2.08) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reliq Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Reliq Health March 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1041 | |||
| Market Risk Adjusted Performance | (2.07) | |||
| Mean Deviation | 295.45 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 1218.61 | |||
| Variance | 1485000.0 | |||
| Information Ratio | 0.123 | |||
| Jensen Alpha | 155.11 | |||
| Total Risk Alpha | 36.86 | |||
| Treynor Ratio | (2.08) | |||
| Maximum Drawdown | 9900.0 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Reliq Health Technologies Backtested Returns
Reliq Health is out of control given 3 months investment horizon. Reliq Health Technologies maintains Sharpe Ratio (i.e., Efficiency) of 0.17, which implies the firm had a 0.17 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for seventeen different technical indicators, which can help you to evaluate if expected returns of 31.67% are justified by taking the suggested risk. Use Reliq Health Coefficient Of Variation of 812.4, variance of 1485000.0, and Risk Adjusted Performance of 0.1041 to evaluate company specific risk that cannot be diversified away. Reliq Health holds a performance score of 13 on a scale of zero to a hundred. The company holds a Beta of -72.08, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Reliq Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Reliq Health is expected to outperform it. Use Reliq Health information ratio and rate of daily change , to analyze future returns on Reliq Health.
Auto-correlation | 0.00 |
No correlation between past and present
Reliq Health Technologies has no correlation between past and present. Overlapping area represents the amount of predictability between Reliq Health time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Reliq Health Technologies price movement. The serial correlation of 0.0 indicates that just 0.0% of current Reliq Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.87 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Reliq Health Technologies reported net income of (8.17 Million). This is 102.39% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The net income for all United States stocks is 101.43% higher than that of the company.
Reliq Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reliq Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Reliq Health could also be used in its relative valuation, which is a method of valuing Reliq Health by comparing valuation metrics of similar companies.Reliq Health is currently under evaluation in net income category among its peers.
Reliq Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.45) % | |||
| Current Valuation | 78.18 M | |||
| Shares Outstanding | 196.76 M | |||
| Shares Owned By Insiders | 1.76 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | (7.07) X | |||
| Price To Book | 16.65 X | |||
| Price To Sales | 6.99 X | |||
| Revenue | 8.55 M | |||
| Gross Profit | 5.3 M | |||
| EBITDA | (8.02 M) | |||
| Net Income | (8.17 M) | |||
| Cash And Equivalents | 890.15 K | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 4.61 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (8.03 M) | |||
| Earnings Per Share | (0.04) X | |||
| Number Of Employees | 13 | |||
| Beta | 1.52 | |||
| Market Capitalization | 73.78 M | |||
| Total Asset | 10.27 M | |||
| Net Asset | 10.27 M |
About Reliq Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reliq Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reliq Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reliq Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Reliq Pink Sheet
Reliq Health financial ratios help investors to determine whether Reliq Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reliq with respect to the benefits of owning Reliq Health security.